Today is February 12 of 2021 and I'm gonna be discussing this new not quite yet peer-reviewed article from the recovery trial collaborative group titled “Tocilizumab for COVID-19” or it might be called “Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): Preliminary results of a randomized, controlled, open-label, platform trial. Should we be giving …
Continue reading Tocilizumab for COVID-19: The Return (RECOVERY Group)